Home › NDC Lookup › RxCUI directory › RxCUI 1729418

1 ML vinorelbine 10 MG/ML Injection — RxCUI 1729418

RxNorm drug concept · Semantic clinical drug
RxCUI 1729418 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1729418
Official name1 ML vinorelbine 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvinorelbine (as vinorelbine tartrate) 10 MG per 1 ML Injection; vinorelbine 10 MG in 1 ML Injection
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)384 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vinorelbine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Vinorelbine Injection is a chemotherapy used to treat non-small cell lung cancer (NSCLC) that has spread — either within the chest or to other parts of the body. Depending on your...
  • What exactly is vinorelbine being used to treat?
  • No, vinorelbine is always given by a nurse or other trained professional through an IV in a clinic, infusion center, or hospital. You can't take it at home. Each infusion takes abo...
  • How will I receive this medication — do I take it at home?
📖 Read our full Vinorelbine Injection guide →

🕸️ Concept Web — How 1 ML vinorelbine 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML vinorelbine 10 MG/ML Injection RxCUI 1729418

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vinorelbine 39541
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Navelbine 53557
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vinorelbine Injection 1729404
    • Vinorelbine Injectable Product 1164585
    • Vinorelbine Injection [Navelbine] 1729407
    • Navelbine Injectable Product 1180490
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Vinorelbine 10 MG/ML 330562
    • 1 ML vinorelbine 10 MG/ML Injection [Navelbine] 1729419
    • Vinorelbine 10 MG/ML [Navelbine] 565262

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vinorelbine 10 MG/ML SCDC · 330562
  • Vinorelbine Injection SCDF · 1729404
  • Vinorelbine Injectable Product SCDG · 1164585

Brand-Name Concepts

  • 1 ML vinorelbine 10 MG/ML Injection [Navelbine] SBD · 1729419
  • Vinorelbine 10 MG/ML [Navelbine] SBDC · 565262
  • Vinorelbine Injection [Navelbine] SBDF · 1729407
  • Navelbine Injectable Product SBDG · 1180490
  • Navelbine BN · 53557

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 1729418 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25021-0204-01 1 VIAL in 1 CARTON (25021-204-01) / 1 mL in 1 VIAL Vinorelbine Sagent Pharmaceuticals 2014-09-15
25021-0204-05 1 VIAL in 1 CARTON (25021-204-05) / 5 mL in 1 VIAL Vinorelbine Sagent Pharmaceuticals 2014-09-15
45963-0607-55 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-607-55) / 1 mL in 1... Vinorelbine Actavis Pharma, Inc. 2015-03-01
45963-0607-56 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-607-56) / 5 mL in 1... Vinorelbine Actavis Pharma, Inc. 2015-03-01
Observed labelers: Actavis Pharma, Inc. (2) · Sagent Pharmaceuticals (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9390 Vinorelbine tartrate inj 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.